Clinical Trials Logo

Filter by:
NCT ID: NCT04335864 Completed - Hydrosalpinx Clinical Trials

Comparing the Impact of 2 Different Techniques in Management of Hydrosalpinx on Pregnancy Rates Following ICSI

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Assessment and comparing pregnancy outcomes in hydrosalpinx patients treated by hysteroscopic tubal occlusion and laparoscopic salpingectomy before ICSI.

NCT ID: NCT04336306 Completed - Clinical trials for Cardiovascular Diseases

Virtual Reality-based Therapy and Barriers in Cardiac Patients

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the chronic hemodynamic and autonomic repercussions of the insertion of VRBT in CR. To qualitatively analyze the perception of patients and physiotherapists regarding the use of VRBT, as well as their association with CR, and through a new questionnaire that takes into account patients 'adherence, identifying which are the main barriers that influence patients' absences.

NCT ID: NCT04336345 Completed - COVID-19 Clinical Trials

Outcomes of Patients With COVID-19 in the Intensive Care Unit

MexCOVID-19
Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

The objective of this study is to evaluate the clinical characteristics and outcomes of critically ill patients with COVID-19 admitted to the intensive care unit. A Multicenter Observational Study.

NCT ID: NCT04336449 Completed - Healthy Clinical Trials

Eptinezumab in Healthy Japanese Subjects

Start date: April 1, 2020
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate how eptinezumab enters, moves through and exits the body. Safety and tolerability will also be investigated.

NCT ID: NCT04336800 Completed - Clinical trials for Diabetes Mellitus, Type 2

Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry)

Start date: April 1, 2020
Phase:
Study type: Observational

To build a registry of diabetic volunteers by inviting them to get a LiverMultiScan and collecting their contact information to seek interest in participating in future research studies.

NCT ID: NCT04339244 Completed - Clinical trials for Optic Nerve Sheath Diameter

Effect of Pressure Regulation on Optic Nerve Sheath Diameter

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Intracranial pressure is known to increase during robot-assisted laparoscopic radical prostatectomy (RALRP) due to steep trendelenberg position. Measurement of optic nerve sheath diameter (ONSD) is a indirect method which can assess the degree of intracranial pressure. This study is designed to measure the ONSD during RALRP under regulation of arterial pressure.

NCT ID: NCT04339491 Completed - Social Isolation Clinical Trials

Physical Activity During Social Isolation

Start date: April 1, 2020
Phase:
Study type: Observational

The aim of the study is to evaluate the physical activity level and the factors affecting physical activity among young adults who are socially isolated due to coronavirus.

NCT ID: NCT04341909 Completed - Pancreas Cancer Clinical Trials

Trainee Involvement in ERCP Risk Score

TIERS
Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

The study aims to evaluate factors associated with an increased risk of procedure related adverse events (including tecnical failure) of endoscopic retrograde cholangiopancreatography procedures (ERCP) conducted in a teaching setting, with trainee involvement.

NCT ID: NCT04343404 Completed - Clinical trials for Respiratory Distress Syndrome

Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

ECMO-COVID-19
Start date: April 1, 2020
Phase:
Study type: Observational

Describe COVID-19 patients who are receiving ECMO-VV respiratory replacement and what happens to them.

NCT ID: NCT04343651 Completed - Clinical trials for Coronavirus Disease 2019

Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19

Start date: April 1, 2020
Phase: Phase 2
Study type: Interventional

This is a Phase 2, two-arm, randomized, double blind, placebo controlled multicenter study to evaluate the safety and efficacy of leronlimab (PRO 140) in patients with mild-to-moderate symptoms of respiratory illness caused by coronavirus 2019 infection.